Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC
University of Pittsburgh
University of Pittsburgh
Genmab
University of Ulm
University of Pittsburgh
University of California, San Diego
Memorial Sloan Kettering Cancer Center
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
Yale University
Instituto Nacional de Cancer, Brazil
University College, London
ARCAGY/ GINECO GROUP
University College, London
Imperial College London
University Health Network, Toronto
Sunnybrook Health Sciences Centre
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
The Netherlands Cancer Institute